American payment processing company Shift4 agreed to acquire specialty payments platform Global Blue. Loyens & Loeff has been advising the buyer, while NKF represented the selling part. The deal Headquartered in Pennsylvania, Shift4 provides more
Tags :Ulysses von Salis
Niederer Kraft Frey advised Luzerner Kantonalbank, acting as agent, and the syndicate of banks on all aspects regarding the amendment of the existing financing for Hochdorf Swiss Nutrition (HSN), in the context of AS Equity
Niederer Kraft Frey has advised MVM Partners on its investment in icotec. Icotec is a leading company in the field of innovative spinal tumor implants and is commercialising groundbreaking BlackArmor Carbon/PEEK products that may
Niederer Kraft Frey (NKF) has provided comprehensive legal guidance to Capvis throughout the financing process for the majority stake acquisition of Schurter Group. The transaction, in which NKF also served as the M&A
NKF advised the Swiss Confederation on the conclusion of a Loss Protection Agreement (LPA) with UBS Group. The loss protection guarantee governed by the LPA is a cornerstone element of the merger between UBS and
Cinerius Financial Partners has bought a majority stake in Swiss wealth management firm Entrepreneur Partners. With Cinerius, the Zurich based wealth management boutique Entrepreneur Partners has a new anchor shareholder and becomes the first Swiss
Niederer Kraft Frey advised Capvis, the specialist in mid-market investments and a well-known Swiss investor, on the investment into AdEx Partners. The growth strategy will be further enhanced through expansion of the service portfolio, internationalization,
Niederer Kraft Frey has advised as lead counsel Capvis, the specialist in mid-market investments and a well-known Swiss investor, on the acquisition of a majority stake in SCHURTER Group. The closing is subject to (European)
As we have informed here, CVC and Partners Group have entered into an agreement for Partners Group to increase its stake in leading Swiss watchmaker Breitling in a transaction that will make it the company’
Niederer Kraft Frey has advised GENFIT, a late-stage biopharmaceutical company, on the acquisition of Versantis. GENFIT is a pioneer in liver disease research and development, publicly traded company listed on the Nasdaq Global Select Market
